Okomera

French tech company | Builders Republic

About

Developer of an automated organoid-screening system for cancer drug discovery — its Ocentra microfluidic platform grows thousands of patient-derived microtumors from tiny cell samples and tests many drug conditions in parallel, with integrated image analysis, for pharma and biotech preclinical research.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Seed
Founded
2020
City
PARIS
Region
IDF
Tracked rounds
1
Amount raised
10 M€ raised since 2020

Funding rounds

  • Seed — 2023

Investors